Remote robotic prostate surgery using telesurgery technology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial uses the Microport Medbot robotic platform to allow a remote surgeon to perform robotic radical or simple prostatectomy on patients located at AdventHealth Celebration. Procedures are done over a secure, high-bandwidth connection while investigators collect data on intraoperative safety, perioperative outcomes, and technical performance measures such as latency and connection stability. The study enrolls adults aged 18–90 with localized prostate cancer or benign prostatic disease who are appropriate candidates for robotic surgery and who lack routine access to on-site robotic expertise. The protocol also documents workflow adaptations and explores telesurgery's potential role in surgical training.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 - 90
* Male or female
* Eligible participants for this telesurgery study must have a clearly defined indication for robotic urologic surgery, specifically:

  * Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy.

OR

-Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention.

* Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field.
* Willing to participate in the study
* Mentally capable of comprehending the study protocol

Exclusion Criteria:

* Patients who, based on multidisciplinary evaluation (surgical, anesthetic, and medical), are deemed not suitable for robotic surgery due to high perioperative risk. This includes but is not limited to:

  * Uncontrolled cardiovascular, pulmonary, or metabolic disease.
  * Severe anesthetic risk classified as ASA Class IV or higher.
* Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes.
* Patients unwilling or unable to comply with the perioperative and follow-up schedule.
* Vulnerable populations are excluded from this study, including:

  * Minors (under 18 years old)
  * Prisoners
  * Cognitively impaired or decisional incapacitated individuals

Where it's running

• AdventHealth
  Celebration, Florida, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding NK Cell Function in Prostate Cancer Across Races

  This study tests whether natural killer (NK) cells behave differently in prostate cancer patients of diverse racial backgrounds by analyzing blood and tissue samples.

  Recruiting Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT07910019

• MRI or CT planning to guide high-dose-rate prostate brachytherapy

  This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.

  Recruiting at 3 sites Emory University · Atlanta, Georgia and 2 other locations · NCT07859722

• Targeted Early Detection for Men at High Genetic Risk for Prostate Cancer

  This study tests urinary biomarkers and PSA to see if they can improve early detection for men with a strong family or genetic risk for prostate cancer.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07645391

• Urine and MRI approach to find aggressive prostate cancer early

  This study tests whether a urine test called MPS2, paired with MRI, can better detect aggressive prostate cancer in men 50–75 at risk, possibly reducing unnecessary biopsies.

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07526545

• GET FIT Together: a socially enhanced exercise program for older men with prostate cancer

  This program tests whether adding structured social support to supervised online exercise reduces cancer-related loneliness and improves mental and physical health in men 65 and older who have had prostate cancer.

  Recruiting OHSU Knight Cancer Institute · Portland, Oregon · NCT07504835

• Improved MRI methods to distinguish benign from cancerous pelvic findings

  This test tries new deep-learning image-processing methods on MRI scans to get clearer images faster for adults scanned for prostate screening or suspected endometriosis.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07407959

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.